Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin Lymphoma Study Group

Journal of Clinical Oncology

Volumn 23, Issue 7, 2005, Pages 1522-1529

  Josting, Andreas ^a   Nogová, Lucia ^a   Franklin, Jeremy ^a   Glossmann, Jan Peter ^a   Eich, Hans Theodor ^a   Sieber, Markus ^a   Schober, Thomas ^a   Boettcher, Heinz Dietrich ^a   Schulz, Ulrich ^a   Müller, Rolf Peter ^a   Diehl, Volker ^a   Engert, Andreas ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; PREDNIMUSTINE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINDESINE; ABVD PROTOCOL; ANTINEOPLASTIC AGENT; BEACOPP PROTOCOL; COPP PROTOCOL;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER RESEARCH; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HODGKIN DISEASE; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SALVAGE THERAPY; STROKE; TREATMENT FAILURE; TREATMENT OUTCOME; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PREDNISONE; PROCARBAZINE; RADIOTHERAPY; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT FAILURE; VINBLASTINE; VINCRISTINE;

EID: 20144367598     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.022     Document Type: Article

References (26)

1. Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. N Engl J Med 327:1478-1483, 1992
2. Carde P, Noordijk E, Hagenbeek A et al: Superiority of EBVP chemotherapy in combination with involved field irradiation over subtotal nodal irradiation in favorable clinical stage I-II Hodgkin's disease: The EORTC-GPMC H7F randomized trial. Proc Amer Soc Clin Oncol 16:13a, 1997 (abstr 44)
3. Connors JM, Klimo P, Adams G, et al: Treatment of advanced Hodgkin's disease with chemotherapy-comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: A report from the National Cancer Institute of Canada clinical trials group. J Clin Oncol 15:1638-1645, 1997
4. Canellos GP: Treatment of relapsed Hodgkin's disease: Strategies and prognostic factors. Ann Oncol 9:S91-S98, 1998 (suppl 5)
5. Linch DC, Winfield D, Goldstone AH, et al: Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomized trial. Lancet 341:1051-1054, 1993
6. Schmitz N, Pfistner B, Sextro M, et al: Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomized trial. Lancet 359:2065-2071, 2002
7. Josting A, Rudolph C, Mapara M, et al: Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: Results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol 16:116-123, 2005
8. Brice P, Divine M, Simon D, et al: Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD): SFGM/GELA Study Group. Ann Oncol 10:1485-1488, 1999
9. Khouri IF, Keating M, Korbling M, et al: Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 16:2817-2824, 1998
10. Wirth A, Corry J, Laidlaw C, et al: Salvage radiotherapy for Hodgkin's disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 39:599-607, 1997
11. Leigh BR, Fox KA, Mack CF, et al: Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 27:855-862, 1993
12. Pezner RD, Lipsett JA, Vora N, et al: Radical radiotherapy as salvage treatment for relapse of Hodgkin's disease initially treated by chemotherapy alone: Prognostic significance of the disease-free interval. Int J Radiat Oncol Biol Phys 30:965-970, 1994
13. Brada M, Eeles R, Ashley S, et al: Salvage radiotherapy in recurrent Hodgkin's disease. Ann Oncol 3:131-135, 1992
14. MacMillan CH, Besell EM: The effectiveness of radiotherapy for localized relapse in patients with Hodgkin's disease (IIB-IVB) who obtained a complete response with chemotherapy alone as initial treatment. Clin Oncol (R Coll Radiol) 6:147-150, 1994
15. Uematsu M, Tarbell NJ, Silver B, et al: Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer 72:207-212, 1993
16. Dühmke E, Franklin J, Pfreundschuh M, et al: Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone. J Clin Oncol 19:2905-2914, 2001
17. Sieber M, Franklin J, Tesch H, et al: Two cycles of ABVD plus extended field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease: Results of the German Hodgkin's Lymphoma Study Group (GHSG) trial HD7. Blood 100:341, 2002 (supp 1)
18. Sieber M, Tesch H, Pfistner B, et al: Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: Final results of the German Hodgkin's Lymphoma Study Group trial HD5. J Clin Oncol 20:476-484, 2002
19. Engert A, Schiller P, Josting A, et al: Involved field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3601-3608, 2003
20. Diehl V, Franklin J, Hasenclever D, et al: BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 16:3810-3821, 1998
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457-81, 1958
22. Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: . International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514, 1998
23. Roach M, Kapp DS, Rosenberg SA, et al: Radiotherapy With Curative Intent: An Option in Selected Patients Relapsing for Advanced Hodgkin's Disease. J Clin Oncol 5:550-555, 1987
24. Josting A, Rueffer U, Franklin J, et al: Prognostic factors and treatment outcome in primary progressive Hodgkin's lymphoma: A report from the German Hodgkin's Lymphoma Study Group (GHSG). Blood 96:1280-1286, 2000
25. Josting A, Franklin J, May M, et al: New prognostic score based on treatment of patients with relapsed Hodgkin lymphoma registered in the database of the German Hodgkin Lymphoma Study Group (GHSG). J Clin Oncol 20:221-230, 2002
26. Desch CE, Lasala MR, Smith TJ, et al: The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse. J Clin Oncol 10:200-209, 1992